[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Hims & Hers Health director Deborah M. Autor was granted 3,656 Restricted Stock Units (RSUs) that convert one-for-one into Class A common shares. The award was recorded as an acquisition of derivative securities and increases her direct beneficial ownership to 3,656 shares at a reported price of $0. The RSUs are subject to a service-based vesting schedule and will vest on the earlier of the company’s 2026 annual meeting or June 15, 2026, provided continuous service.

This filing reflects an equity grant to a board director rather than a cash transaction or sale, creating potential alignment between the director and shareholders through future ownership if vesting conditions are met.

Insights

Corporate Governance Expert

TL;DR: Director RSU award aligns incentives with shareholders; schedule is service-based and appears routine, with no immediate cash change.

The Form 4 shows a grant of 3,656 RSUs to Director Deborah M. Autor that convert to Class A common stock on a one-for-one basis. Vesting is contingent on continuous service and occurs by the earlier of the 2026 annual meeting or June 15, 2026. The grant increases direct beneficial ownership without any indicated sale or cash consideration. From a governance perspective this is a standard tool to align board members with shareholder interests; the filing itself contains no evidence of unusual terms or acceleration events.

Compensation/Equity Analyst

TL;DR: A routine director equity grant of 3,656 RSUs with service-vesting; limited immediate dilution and no cash outlay reported.

The reported derivative award is a Restricted Stock Unit grant representing 3,656 underlying shares at a reported derivative price of $0. The RSUs convert to Class A common stock upon vesting under the stated schedule. The form does not disclose market value, grant-date fair value, or any hedging arrangements. Without company-wide grant totals or outstanding share counts in this filing, the absolute dilution or accounting impact cannot be quantified from the document alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Autor Deborah M.

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/06/2025		A		3,656		(1)	(1)	Class A Common Stock	3,656	$0	3,656	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the HIMS Form 4 disclose about Deborah M. Autor?

The Form 4 shows a grant of 3,656 Restricted Stock Units (RSUs) that convert one-for-one to Class A common stock, increasing her direct beneficial ownership to 3,656 shares.

When was the RSU transaction for HIMS reported?

The transaction date reported on the Form 4 is 08/06/2025 as the date the RSUs were granted.

When will the HIMS RSUs vest for Deborah Autor?

The RSUs vest on the earlier of the company’s 2026 annual meeting or June 15, 2026, subject to continuous service.

Did the Form 4 show any sales or disposals by Deborah Autor at HIMS?

No. The filing records an acquisition of derivative securities (RSUs); there are no disposals or sales reported in this Form 4.

Who signed or filed the Form 4 for Deborah Autor?

The filing is executed by Alexandra Cotter Wilkins, Attorney-in-Fact on behalf of the reporting person as indicated on the form.